The global acoustic respiration sensors market is estimated to secure a market value of US$ 247.1 million in 2023. From 2023 to 2033, the market is expected to expand at a CAGR of 6.6% while garnering a market value worth US$ 468.9 million by 2033. This market's expansion is mainly driven by an increasing number of respiratory diseases as well as increased awareness about respiratory health.
Respiratory diseases are a leading cause of death in both children and adults, fueling the demand for respiratory monitoring devices. Furthermore, advances in sensor technology have resulted in an increase in adoption rates among hospitals and clinics, thus, the market is projected to experience a notable expansion in the forthcoming period.
| Attributes | Details |
|---|---|
| Historical Value (2022) | US$ 232.4 million |
| Current Year Value (2023) | US$ 247.1 million |
| Expected Forecast Value (2033) | US$ 468.9 million |
| Projected CAGR (2023 to 2033) | 6.6% |
Acoustic respiration sensors enable healthcare providers and clinicians to monitor a patient's breathing in real-time. It is a non-invasive technology that aids in the early detection of respiratory distress in patients. This technology employs novel adhesive sensors with an acoustic transducer, allowing for continuous monitoring of breathing patterns. The product is useful for detecting emerging respiratory disorders and providing patients with prompt therapeutic responses to reduce the risk of dangerous respiratory events. Increasing demand for non-invasive technology devices is likely to open various avenues of expansion in the market in the forthcoming period.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Acoustic respiration sensors enable healthcare providers and clinicians to oversee a patient's breathing in real-time. It is a non-invasive technology that aids in the early detection of respiratory distress in patients. This technology employs novel adhesive sensors with an acoustic transducer, allowing for continuous monitoring of breathing patterns.
| Historical CAGR (2018 to 2022) | 6.1% |
|---|---|
| Forecasted CAGR (2023 to 2033) | 6.6% |
The product is useful for detecting emerging respiratory disorders and providing patients with immediate therapeutic responses to alleviate the risk of catastrophic respiratory failures. Increasing demand for non-invasive technology devices is likely to open various avenues of expansion in the market in the forthcoming period.
The acoustic respiration sensors market is primarily driven by a few key factors, such as the use of respiratory sensors to provide non-invasive and steadfast monitoring to patients. The increasing prevalence of respiratory disorders, an aging population, and an increase in life expectancy will drive the market in the forecast period.
The Anesthesia Patient Safety Foundation (APSF) recommends using multiple parameters to detect respiratory disorders before they progress to respiratory breakdowns, such as pulse oximetry and respiration rate. Paediatrics is more prone to respiratory diseases. Thus, the demand for Acoustic Respiration Sensors is expected to skyrocket in the forthcoming period.
This technology is a reprieve to the healthcare industry because it provides early warning of respiratory distress, allowing physicians and other healthcare providers to provide early care, and potentially improve patient safety and health. The market for acoustic respiration sensors is being driven by new product approvals from various regulatory agencies around the world. Such rapid developments in the market are expected to offer significant market growth opportunities in the forecast period.
In addition, the acoustic respiration sensors market is experiencing significant growth with rising healthcare expenditure in developing countries. The use of acoustic respiration sensors in addressing evolving respiratory issues is driving the market. The market is also being driven by increased awareness among end users as a result of various associations. Such factors are anticipated to boost market growth in the assessment period.
The acoustic respiration sensors market in the healthcare sector is primarily driven by a few key factors such as the use of respiratory sensors to provide non-invasive and continuous monitoring to patients. The growing incidence of respiratory disorders, the aging population, and the rise in life expectancy are certified market denominators of growth. In addition to this acoustic respiration sensors market also observes significant growth due to increasing healthcare expenditure in developing countries.
Principal Consultant
Lack of technical fluency is projected to hinder market growth in the forecast period. Also, dearth of awareness about the benefits of the sensors, the market is likely to suffer in the forthcoming time. Furthermore, high costs associated with the acoustic respiration sensors is another factor limiting the market growth.
| Regions | 2022 Value Share in Global Market |
|---|---|
| North America | 41.2% |
| Europe | 27.8% |
Intensive Research and Development and product innovation to favor growth
The North America Acoustic Respiration Sensor market held a market share of 41.2% in 2022. North America is expected to dominate the respiration rate monitors market during the forecast period with a large focus on research and development activities and product innovation in the region. Europe tends to be the second leading region in the respiration rate monitors market with a high geriatric population and availability of advanced healthcare technology.
The rules of the USA Food and Drug Administration drive the North American market. Such regulations and approvals are likely to enhance the North American acoustic respiration sensor market in the coming years.
North America holds a leading position in the respiration sensor market due to regulations of the drug and USA food administration. Such approval and regulations are expected to increase the respiration sensor market in the North American region during the forecast period.
Europe's exponential growth with a strong presence of players in the region
European countries are also predicted to show exponential growth in the respiration sensor market. The rising development and emergence of numerous regional players in Europe, results in significant growth in the respiration sensor market, in upcoming years. The respiration sensor market would grow rapidly across the regions.
Asia Pacific market witness to the rapid development of healthcare system exudes growth
Asia-Pacific will see stupendous growth in the acoustic respiration sensors market in the coming years, as it is developing at a scintillating pace and has seen the emergence of many regional players. Rising healthcare infrastructure and rapid development of healthcare infrastructure across Asian countries will drive the growth of the Asia-Pacific acoustic respiration sensors market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Countries | Value CAGR (2023 to 2033) |
|---|---|
| United Kingdom | 4.6% |
| China | 7.9% |
| India | 6.5% |
Respiratory disorders, such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea, are prevalent in the United States. Over 34 million individuals in the United States suffer from chronic lung conditions such as asthma and COPD, encompassing emphysema and chronic bronchitis. Additionally, over 16 million adults in the United Satiates have been diagnosed with some form of COPD. According to the Asthma and Allergy Foundation of America's April 2022 report, asthma affects about 25 million individuals in the United States annually.
The market in the United States is poised for significant growth in the coming years. Increasing demand for non-invasive monitoring devices, technological advancements, the growing prevalence of respiratory disorders, and the emphasis on patient safety are driving market growth. However, adherence to stringent regulatory requirements, competition among market players, and the reimbursement scenario are crucial factors likely to shape the market's future landscape positively.
Several factors, including the rising prevalence of respiratory disorders such as COPD, TB, asthma, lung cancer, and sleep apnea, fuel the market growth. A study published in the Journal of Asthma and Allergy in July 2022 highlighted that asthma is a prevalent chronic disease in Germany, affecting around 4-5% of all adults and 10% of children each year. Consequently, the substantial burden of asthma in the country is anticipated to drive an increase in demand for respiratory devices, thereby stimulating the Germany acoustic respiration sensors market during the projected period.
The growing trend of wearable devices in healthcare is positively influencing the adoption of acoustic respiration sensors in Germany. These sensors can be integrated into wearable devices such as smartwatches and fitness bands, enabling continuous respiratory monitoring in real time. The convenience and portability offered by wearable devices are driving their popularity among patients and healthcare providers alike.
The Japan acoustic respiration sensors market is witnessing significant growth due to the increasing adoption of advanced healthcare technologies, rising awareness about respiratory disorders, and the growing geriatric population. Japan has one of the world's largest aging populations, leading to an increased demand for healthcare services, including respiratory monitoring devices. According to the "Japanese Guidelines for Adult Asthma 2020" study published in September 2020, there has been a notable increase in the average prevalence of asthma in Japan. The study found that the prevalence has risen from 1.0% to 10.0% or even higher in children, and from 6.0% to 10.0% in adults, in the year 2020 compared to previous years.
The integration of acoustic respiration sensors with AI technologies is gaining traction in Japan. AI algorithms can analyze respiratory data to detect abnormalities and predict impending respiratory events, assisting healthcare professionals in making timely interventions.
| Countries | 2022 Value Share in Global Market |
|---|---|
| United States | 36.4% |
| Germany | 6.6% |
| Japan | 4.1% |
The United Kingdom acoustic respiration sensors market has grown substantially due to the increasing adoption of respiratory monitoring systems, the rising geriatric population, and the prevalence of respiratory disorders. The United Kingdom sees about 585,000 diagnoses of respiratory diseases annually, with half of them attributed to asthma and COPD. Key trends, such as technological advancements, adoption in homecare settings, and a focus on patient comfort, are shaping the market landscape.
The country has a healthcare system that focuses on preventive care and early detection of diseases. The United Kingdom's healthcare system, the NHS, plays a crucial role in shaping the market dynamics. The NHS's commitment to improving patient outcomes and reducing healthcare costs creates opportunities for innovative respiratory monitoring solutions like acoustic respiration sensors.
China has a significant aging population, prone to respiratory disorders such as chronic obstructive pulmonary disease (COPD) and sleep apnea. Based on the GBD 2019 report, there has been a significant 61.2% increase in the number of new cases of COPD, rising from 2.39 million in 1990 to 3.97 million in 2019. This rise can be attributed to several key factors, including the high prevalence of respiratory diseases in China, the continuation of economic and demographic trends, technological advancements, and the expanding use of respiratory care in home settings. For example, an article published by the National Library of Medicine in October 2021 highlights that COPD remains a prominent public health issue in China.
China has a robust healthcare infrastructure with a high emphasis on patient care and safety. The country's well-established healthcare system and favorable reimbursement policies encourage the adoption of advanced medical devices. Acoustic respiration sensors, being an integral part of patient monitoring systems, are expected to witness increased adoption in the China healthcare sector.
The rapid urbanization and significant pollution levels in India have played an important role in increasing the occurrence of respiratory diseases in the country. For example, a study published by PubMed in August 2021 revealed that the prevalence of COPD among individuals aged 30 years and above in India was 7%. These studies highlighting the prevalence of respiratory diseases in India are generating a surge in demand for respiratory devices, thereby driving the growth of the India acoustic respiration sensors market.
The increasing focus on remote patient monitoring and telehealth services has led to the adoption of acoustic respiration sensors in home healthcare settings in India. These sensors enable healthcare providers to monitor patients' respiratory parameters remotely, enhancing patient care and reducing the burden on healthcare facilities.
| Segment | 2022 Value Share in Global Market |
|---|---|
| Adults Patient Age Groups | 57.8% |
| Sales via Specialized Care Centers | 63.3% |
Several factors drive the dominance of the adult age group in the market:
The dominance of the sales via specialized care centers segment in the acoustic respiration sensors market by distribution channels can be attributed to several factors. Specialized care centers possess expertise and specialization in respiratory care, with healthcare professionals who are highly knowledgeable in this field. They offer comprehensive care for patients with specific respiratory conditions, including diagnosis, treatment, and monitoring. By collaborating closely with medical device manufacturers, these centers ensure access to the latest advancements in acoustic respiration sensors. They also serve as referral points for patients who require specialized respiratory care, attracting a steady flow of patients seeking respiratory monitoring solutions.
Acurable
Provider of a connected wearable device for remote monitoring of health.
Provider of a connected wearable device for remote health monitoring. It has developed a wearable patch that can capture respiratory and cardiac acoustic signals. The device is fixed near the neck of the user using an adhesive bandage and when turned on the device reads the acoustic signals of the body using a microsensor.
Advanced Telesensors
Advanced TeleSensors is using patented contactless heart and respiration sensing technology to develop devices that can gather vital data through obstruction during natural motion without any need for wired sensor pads leading to cost-cutting. ATS technology is capable of automatically locking on to an individual’s pulse, respiration, and movement in their residence, which can then be transmitted to a centralized health care system enabling advanced home care.
All manufacturers of the respiration sensor market are mainly focusing on the product design, to increase productivity. It is expected that with due course of time, there will be an influx of well-established players in the acoustic respiration sensors market.
Major players in the respiration rate monitors market are GE Healthcare, Siemens Healthcare, Philips Healthcare, Medtronic Plc, Masimo Corporations, ResMed Inc., Smiths Medical, Dragerwerk Ag & Co. KGaA, MGC Diagnostic Corporation, Nihon Kohden Corporation, Welch Allyn, Inc, and others.
It is envisaged that robust players will enter the acoustic respiration sensors market in due course. Many regional and multi-national players with a large market share in emerging and developed economies are present in the acoustic respiration sensors market.
Key Companies Profiled
The global market is estimated to be valued at US$ 247.1 million in 2023.
The global market recorded US$ 232.4 million in 2022, exhibiting a CAGR of 6.1%.
The global market is expected to progress at a CAGR of 6.6%.
The United States is likely to embrace the maximum share in the global market by 2033.
The global market is predicted to account for US$ 468.9 million by 2033.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Patient Age Groups 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Patient Age Groups, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Patient Age Groups, 2023 to 2033 5.3.1. Adults 5.3.2. Pediatrics 5.4. Y-o-Y Growth Trend Analysis By Patient Age Groups, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Patient Age Groups, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channels 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Distribution Channels, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Distribution Channels, 2023 to 2033 6.3.1. Sales via Specialized Care Centers 6.3.2. Sales 6.4. Y-o-Y Growth Trend Analysis By Distribution Channels, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Distribution Channels, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022 7.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033 7.3.1. North America 7.3.2. Latin America 7.3.3. Western Europe 7.3.4. Eastern Europe 7.3.5. South Asia and Pacific 7.3.6. East Asia 7.3.7. Middle East and Africa 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 8.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 8.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 8.2.1. By Country 8.2.1.1. U.S. 8.2.1.2. Canada 8.2.2. By Patient Age Groups 8.2.3. By Distribution Channels 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Patient Age Groups 8.3.3. By Distribution Channels 8.4. Key Takeaways 9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Patient Age Groups 9.2.3. By Distribution Channels 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Patient Age Groups 9.3.3. By Distribution Channels 9.4. Key Takeaways 10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. U.K. 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Western Europe 10.2.2. By Patient Age Groups 10.2.3. By Distribution Channels 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Patient Age Groups 10.3.3. By Distribution Channels 10.4. Key Takeaways 11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Poland 11.2.1.2. Russia 11.2.1.3. Czech Republic 11.2.1.4. Romania 11.2.1.5. Rest of Eastern Europe 11.2.2. By Patient Age Groups 11.2.3. By Distribution Channels 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Patient Age Groups 11.3.3. By Distribution Channels 11.4. Key Takeaways 12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Bangladesh 12.2.1.3. Australia 12.2.1.4. New Zealand 12.2.1.5. Rest of South Asia and Pacific 12.2.2. By Patient Age Groups 12.2.3. By Distribution Channels 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Patient Age Groups 12.3.3. By Distribution Channels 12.4. Key Takeaways 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Patient Age Groups 13.2.3. By Distribution Channels 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Patient Age Groups 13.3.3. By Distribution Channels 13.4. Key Takeaways 14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. South Africa 14.2.1.3. Israel 14.2.1.4. Rest of MEA 14.2.2. By Patient Age Groups 14.2.3. By Distribution Channels 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Patient Age Groups 14.3.3. By Distribution Channels 14.4. Key Takeaways 15. Key Countries Market Analysis 15.1. U.S. 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2022 15.1.2.1. By Patient Age Groups 15.1.2.2. By Distribution Channels 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2022 15.2.2.1. By Patient Age Groups 15.2.2.2. By Distribution Channels 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2022 15.3.2.1. By Patient Age Groups 15.3.2.2. By Distribution Channels 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2022 15.4.2.1. By Patient Age Groups 15.4.2.2. By Distribution Channels 15.5. Germany 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2022 15.5.2.1. By Patient Age Groups 15.5.2.2. By Distribution Channels 15.6. U.K. 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2022 15.6.2.1. By Patient Age Groups 15.6.2.2. By Distribution Channels 15.7. France 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2022 15.7.2.1. By Patient Age Groups 15.7.2.2. By Distribution Channels 15.8. Spain 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2022 15.8.2.1. By Patient Age Groups 15.8.2.2. By Distribution Channels 15.9. Italy 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2022 15.9.2.1. By Patient Age Groups 15.9.2.2. By Distribution Channels 15.10. Poland 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2022 15.10.2.1. By Patient Age Groups 15.10.2.2. By Distribution Channels 15.11. Russia 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2022 15.11.2.1. By Patient Age Groups 15.11.2.2. By Distribution Channels 15.12. Czech Republic 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2022 15.12.2.1. By Patient Age Groups 15.12.2.2. By Distribution Channels 15.13. Romania 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2022 15.13.2.1. By Patient Age Groups 15.13.2.2. By Distribution Channels 15.14. India 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2022 15.14.2.1. By Patient Age Groups 15.14.2.2. By Distribution Channels 15.15. Bangladesh 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2022 15.15.2.1. By Patient Age Groups 15.15.2.2. By Distribution Channels 15.16. Australia 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2022 15.16.2.1. By Patient Age Groups 15.16.2.2. By Distribution Channels 15.17. New Zealand 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2022 15.17.2.1. By Patient Age Groups 15.17.2.2. By Distribution Channels 15.18. China 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2022 15.18.2.1. By Patient Age Groups 15.18.2.2. By Distribution Channels 15.19. Japan 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2022 15.19.2.1. By Patient Age Groups 15.19.2.2. By Distribution Channels 15.20. South Korea 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2022 15.20.2.1. By Patient Age Groups 15.20.2.2. By Distribution Channels 15.21. GCC Countries 15.21.1. Pricing Analysis 15.21.2. Market Share Analysis, 2022 15.21.2.1. By Patient Age Groups 15.21.2.2. By Distribution Channels 15.22. South Africa 15.22.1. Pricing Analysis 15.22.2. Market Share Analysis, 2022 15.22.2.1. By Patient Age Groups 15.22.2.2. By Distribution Channels 15.23. Israel 15.23.1. Pricing Analysis 15.23.2. Market Share Analysis, 2022 15.23.2.1. By Patient Age Groups 15.23.2.2. By Distribution Channels 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Patient Age Groups 16.3.3. By Distribution Channels 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. Masimo Corporation 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.1.5.2. Product Strategy 17.1.1.5.3. Channel Strategy 17.1.2. Medtronic plc 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.2.5.2. Product Strategy 17.1.2.5.3. Channel Strategy 17.1.3. Nonin Medical, Inc. 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.3.5.2. Product Strategy 17.1.3.5.3. Channel Strategy 17.1.4. Koninklijke Philips N.V. 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.4.5.2. Product Strategy 17.1.4.5.3. Channel Strategy 17.1.5. Nihon Kohden Corporation 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.5.5.2. Product Strategy 17.1.5.5.3. Channel Strategy 17.1.6. Smiths Group plc (Smiths Medical) 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.6.5.2. Product Strategy 17.1.6.5.3. Channel Strategy 17.1.7. Vyaire Medical, Inc. 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.7.5.2. Product Strategy 17.1.7.5.3. Channel Strategy 17.1.8. GE Healthcare 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.8.5.2. Product Strategy 17.1.8.5.3. Channel Strategy 17.1.9. Mindray Medical International Limited 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.9.5.2. Product Strategy 17.1.9.5.3. Channel Strategy 17.1.10. Zephyr Sleep Technologies Inc. 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 17.1.10.5.2. Product Strategy 17.1.10.5.3. Channel Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports
Acoustic Respiration Sensors Market
